Purchase of Medicines for RSNPMC Hematology

• Country: Uzbekistan
• Summary: Purchase of Medicines for RSNPMC Hematology
• UZT Ref No: 82076053
• Deadline: 28 Apr 2023
• Financier: Self Financed
• Purchaser Ownership: Government
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.:
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• Tenders are invited for Purchase of Medicines for RSNPMC Hematology 1 L-asparaginase L-asparaginase lyophilized powder for intravenous and intramuscular administration, 10000 IU Lyophilisate for preparation of solution for injection 10000 IU vial 8,646 3,600 47,88,000 407.19 17,236.80 2 Albumin Albumin solution for infusion 20% - 100 ml Solution for infusion 20% 100 ml bottle 3,045 1,025 6,25,000 53.15 640.63 3 Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) Lyophilisate for infusion 25 mg Lyophilisate for preparation of infusion solution 25 mg bottle 2,025 100 24,51,000 208.44 245.10 4 Antithymocyte immunoglobulin (fog) Antithymocyte immunoglobulin (horse) Lyophilisate for infusion 50 mg Lyophilisate for preparation of infusion solution 50 mg bottle 4,825 650 49,95,000 424.79 3,246.75 5 Bendamustine Bendamustine Lyophilisate for preparation of concentrate for infusion solution 100 mg Powder lyophilized for IV administration 100 mg bottle 1,520 500 3,99,000 33.93 199.50 6 Bleomycin Bleomycin concentrate for infusion solution 15 mg or IU Lyophilisate for preparation of solution for injection 15 ED N1 ampoule 1,200 1,200 1,63,122 13.87 195.75 7 Bortezamib Bortezamib Lyophilisate for intravenous and intramuscular administration 2.5 mg Lyophilisate for preparation of solution for intravenous and subcutaneous administration 2.5 mg N1 bottle 3,318 1,000 4,13,364 35.15 413.36 8 Busulfan Busulfan Film-Coated Tablets 2.0 mg Film-Coated Tablets 2.0 mg Tablets 6,000 2,000 7,04,770 59.94 1,409.54 9 Vincristine Vincristine solution for intravenous administration 1.0 mg Solution for intravenous administration 1.0 mg/2 ml bottle 18,179 11,500 47,880 4.07 550.62 10 Hydroxycarbamide Hydroxycarbamide Capsules, 500 mg Capsules of 500 mg capsules 96,785 40,400 2,333 0.20 94.27 11 Dacarbazine Dacarbazine lyophilized powder for infusion 200 mg Lyophilisate for preparation of solution for IV administration 200 mg ampoule 675 675 1,61,000 13.70 108.68 12 Doxorubicin Doxorubicin lyophilisate for intravenous, intra-aortic, intra-vesical administration, 2.0 mg/ml - 5.0 ml (10 mg) Concentrate or lyophilized powder for preparation of solution for infusion 10 mg ampoule 13,801 8,100 39,900 3.39 323.19 13 Doxorubicin Doxorubicin lyophilisate for intravenous, intra-aortic, intra-vesical administration, 2.0 mg/ml - 25.0 ml (50 mg) Concentrate or lyophilized powder for preparation of solution for infusion 50 mg ampoule 2,765 1,740 91,200 7.76 158.69 14 Docetaxel Docetaxel concentrate for solution for infusion 80 mg/4 ml Concentrate for preparation of solution for infusion 50 mg ampoule 15 15 2,76,940 23.55 4.15 15 Idarubicin Idarubicin intravenous solution 1 mg/ml-5.0 ml (5 mg) Solution for preparation of solution for intravenous administration 1 mg/1 ml: 5 ml fl. vial 9,133 2,000 8,60,758 73.20 1,721.52 16 Normal human immunoglobulin Immunoglobulin human, normal Solution for infusion 50mg/ml-100ml Solution for infusion 50mg/ml-100ml vial 7,499 2,800 39,50,000 335.92 11,060.00 17 Normal human immunoglobulin Immunoglobulin human, normal Solution for infusion 50mg/ml-200ml Solution for infusion 50mg/ml-200ml vial 4,375 1,800 66,81,000 568.18 12,025.80 18 Normal human immunoglobulin Immunoglobulin human, normal Solution for infusion 50mg/ml-20ml Solution for infusion 50mg/ml-20ml vial 11,548 4,000 9,76,000 83.00 3,904.00 19 Normal human immunoglobulin Immunoglobulin human, normal Solution for infusion 50mg/ml-50ml Solution for infusion 50mg/ml-50ml vial 5,000 2,000 12,82,500 109.07 2,565.00 20 Calcium folinate Calcium folinate lyophilisate for preparation of injection solution for intravenous and intramuscular administration 50 mg Solution for injection and infusion 50 mg/5 ml N1 vial 15,774 10,550 66,300 5.64 699.47 21 Carboplatin Carboplatin concentrate for infusion solution 450 mg/45 ml Concentrate or lyophilized powder for preparation of solution for injection 450 mg/45 ml N1 ampoule 900 900 5,93,712 50.49 534.34 22 Carboplatin Carboplatin concentrate for infusion solution 150 mg/15 ml Concentrate or lyophilized powder for preparation of solution for injection 150 mg/15 ml N1 ampoule 4,500 4,500 2,54,448 21.64 1,145.02 23 Caspofungin Caspofungin Lyophilisate for preparation of infusion solution 50 mg Lyophilisate for preparation of solution for infusion 50 mg N1 vial 5,160 1,900 9,60,000 81.64 1,824.00 24 Blood Coagulation Factor VIII Human Blood Coagulation Factor VIII Lyophilisate for intravenous administration 500 IU Lyophilisate for preparation of infusion solution 500 IU N1 vial 23,821 11,500 7,61,910 64.80 8,761.97 25 Blood coagulation factor VIII Human blood coagulation factor VIII Lyophilisate for intravenous administration 1000 IU Lyophilisate for preparation of infusion solution 1000 IU N1 vial 12,854 8,500 15,99,420 136.02 13,595.07 26 Concoagulation sining VIII omili Human blood clotting factor VIII Vein ichiga yuborish uchun muljallangan lyophilisate 250 IU Lyophilisate for solution for infusion 250 IU N1 vial 7,583 4,100 6,27,000 53.32 2,570.70 27 Methotrexate Methotrexate Injection uchun erythma taierlash uchun concentrate 10 mg/ml - 5.0 ml (50 mg) Concentrate for infusion solution 10 mg/ml - 5.0 ml (50 mg) vial 5.696 2.882 3.82.734 32.55 1.103.04 28 Methotrexate Methotrexate Infusion erythma taierlash uchun concentrate 500 mg/5 ml Concentrate for infusion solution 500 mg/5 ml vial 750 750 2,40,000 20.41 180.00 29 Methotrexate Methotrexate Injection uchun erythma 10 mg/ml - 100 ml (1000 mg) Concentrate for infusion solution 10 mg/ml - 100 ml (1000 mg) vial 1,808 1,300 4,86,012 41.33 631.82 30 Pegasparginase Peg-asparginase Vena ichiga yuborish uchun muljallangan lyophilisate 3750 IU Lyophilisate for infusion solution 3750 IU vial 363 150 11.72.316 99.70 175.85 31 Rituximab Rituximab Infusion erythma uchun concentrate 100 mg/10 ml Concentrate for solution for infusion 100 mg/10 ml ampoule 1,200 1,200 27,24,600 231.71 3,269.52 32 Rituximab Rituximab Infusion erythma uchun concentrate 500 mg/50 ml Concentrate for solution for infusion 500 mg/50 ml ampoule 725 550 24,15,600 205.43 1,328.58 33 Temozolomide Temozolomide Capsule, 20 mg Capsule 20 mg ampoule 150 150 1,30,000 11.06 19.50 34 Temozolomide Temozolomide Erythma tayorlash uchun kukun 100 mg Lyophilisate for infusion solution 100 mg ampoule 30 30 1,41,970 12.07 4.26 35 Arsenic trioxide Arsenic trioxide Infusion erythma taierlash uchun concentrate 1 mg/1 ml Concentrate for infusion solution 1 mg/1 ml ampoule 11,280 4,000 13,66,400 116.20 5,465.60 36 Filgrastim Filgrastim Vena ichiga wa mushak ichiga yuborish uchun muljallangan erythma 30 million U/ml Solution for intravenous and subcutaneous injection 30 million U/0.5 ml vial/syringe pen 15,349 7,790 1,35,660 11.54 1,056.79 37 Fludarabine Fludarabine Vena ichiga auborish uchun muljallangan eki lyophilisate concentrate, 50 mg Concentrate for preparation of intravenous solution 50 mg vial 563 260 3.51.920 29.93 91.50 38 Fluorouracil Fluorouracil Infusion tayorlash uchun concentrate 250 mg/5 ml Concentrate for solution for infusion 250 mg/5 ml, N1 ampoule 375 375 79,300 6.74 29.74 39 Cyclosporine Cyclosporine Infusion uchun erythma taierlash uchun concentrate, 50 mg Concentrate for solution for infusion, 50 mg ampoule 1,500 750 11,400 0.97 8.55 40 Cyclosporine Cyclosporine Capsule 25 mg Capsule 25 mg capsule 4,500 2,500 3,887 0.33 9.72 41 Cyclosporine Cyclosporine Capsule 50 mg Capsule 50 mg capsule 15.671 6.000 7.878 0.67 47.27 42 Cyclosporine Cyclosporine capsule 100 mg capsule 100 mg capsule 1.247 600 15.756 1.34 9.45 43 Cyclophosphamide Cyclophosphamide Vena ichiga yuborish uchun muljallangan lyophilisate yoki kukun 200 mg Powder for infusion solution 200 mg vial 61,750 37,000 45,600 3.88 1,687.20 44 Cyclophosphamide Cyclophosphamide Vena ichiga yuborish uchun muljallangan lyophilisate yoki kukun 500 mg Powder for infusion solution 500 mg vial 150 150 90,000 7.65 13.50 45 Cisplatin Cisplatin Injection uchun erythma 25 mg Concentrate for solution for infusion 25 mg ampoule 1,500 1,500 17,500 1.48 26.25 46 Cisplatin Cisplatin Injection uchun erythma 50 mg Concentrate for solution for infusion 50 mg ampoule 1,200 1,200 22,820 1.94 27.38 47 Cisplatin Cisplatin Injection uchun erythma 100 mg Concentrate for solution for infusion 100 mg ampoule 1,200 1,200 2,26,974 19.30 272.37 48 Cytarabine Cytarabine Injection erythma taierlash uchun lyophilisate 100 mg Lyophilized powder or solution for infusion 100 mg vial 60,700 30,500 28,500 2.42 869.25 49 Cytarabine Cytarabine Injection erythma taierlash uchun lyophilisate 1000 mg Lyophilized powder or solution for infusion 1000 mg vial 2,700 1,450 3,00,846 25.59 436.23 50 Erythropoietin Recombinant human erythropoietin Vena ichiga vateri ostiga yuborish uchun erythma 2000 IU/ml Injection solution 2000 IU/ml ampoule 3,000 3,000 1,34,178 11.41 402.53 51 Erythropoietin Recombinant human erythropoietin Vena ichiga vateri ostiga yuborish uchun erythma 10,000 IU/ml Injection solution 10,000 IU/ml ampoule 9,000 4,000 95,000 8.08 380.00 In case of awarding the contract, the winning company must, within 5 working days , provide a guarantee of securing its proposal in the form of a deposit, by transferring funds to the settlement account of O'zmedimpeks LLC in the amount of 2% of the total contract amount, before the contract enters into force by virtue of. The amount of the deposit will be returned to the Winner after the full fulfillment of obligations under the contract. In case of non-fulfillment (including refusal to fulfill) contractual obligations by the Winner, the amount of the deposit will remain with the Buyer. At the same time, bidders should take into account that, in accordance with the Regulations of the Decree of the Cabinet of Ministers of the Republic of Uzbekistan. No. 185 of 04/06/2017 The supplier must have and provide an appropriate license to carry out pharmaceutical activities, according to
• Documents:

 Tender Notice